Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 138

Similar articles for PubMed (Select 18510338)

1.

Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.

Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE.

Mol Pharm. 2008 Jul-Aug;5(4):487-95. doi: 10.1021/mp800032f. Epub 2008 May 30. Review.

2.

Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking.

Duan X, Li Y.

Small. 2013 May 27;9(9-10):1521-32. doi: 10.1002/smll.201201390. Epub 2012 Sep 28. Review.

PMID:
23019091
3.

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE.

Adv Drug Deliv Rev. 2009 Jun 21;61(6):428-37. doi: 10.1016/j.addr.2009.03.009. Epub 2009 Apr 17. Review.

4.

Factors affecting the clearance and biodistribution of polymeric nanoparticles.

Alexis F, Pridgen E, Molnar LK, Farokhzad OC.

Mol Pharm. 2008 Jul-Aug;5(4):505-15. doi: 10.1021/mp800051m. Epub 2008 Aug 4. Review.

5.

Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake.

Walkey CD, Olsen JB, Guo H, Emili A, Chan WC.

J Am Chem Soc. 2012 Feb 1;134(4):2139-47. doi: 10.1021/ja2084338. Epub 2012 Jan 23.

PMID:
22191645
6.

Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: impact on macrophage uptake.

Lartigue L, Wilhelm C, Servais J, Factor C, Dencausse A, Bacri JC, Luciani N, Gazeau F.

ACS Nano. 2012 Mar 27;6(3):2665-78. doi: 10.1021/nn300060u. Epub 2012 Feb 16.

PMID:
22324868
7.

Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.

Ilinskaya AN, Dobrovolskaia MA.

Nanomedicine (Lond). 2013 May;8(5):773-84. doi: 10.2217/nnm.13.48. Review.

PMID:
23656264
8.

Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems.

Karmali PP, Simberg D.

Expert Opin Drug Deliv. 2011 Mar;8(3):343-57. doi: 10.1517/17425247.2011.554818. Epub 2011 Feb 4. Review.

PMID:
21291354
9.

Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

Ali Khan A, Mudassir J, Mohtar N, Darwis Y.

Int J Nanomedicine. 2013;8:2733-44. doi: 10.2147/IJN.S41521. Epub 2013 Jul 26. Review.

10.

Drug delivery and nanoparticles:applications and hazards.

De Jong WH, Borm PJ.

Int J Nanomedicine. 2008;3(2):133-49. Review.

11.

Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery.

Huang RB, Mocherla S, Heslinga MJ, Charoenphol P, Eniola-Adefeso O.

Mol Membr Biol. 2010 Oct;27(7):312-27. doi: 10.3109/09687688.2010.522117. Review.

PMID:
21028938
12.
13.

Shape engineering vs organic modification of inorganic nanoparticles as a tool for enhancing cellular internalization.

Karaman DS, Desai D, Senthilkumar R, Johansson EM, Råtts N, Odén M, Eriksson JE, Sahlgren C, Toivola DM, Rosenholm JM.

Nanoscale Res Lett. 2012 Jul 1;7(1):358. doi: 10.1186/1556-276X-7-358.

14.

Challenges in development of nanoparticle-based therapeutics.

Desai N.

AAPS J. 2012 Jun;14(2):282-95. doi: 10.1208/s12248-012-9339-4. Epub 2012 Mar 10. Review.

15.

Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo.

Allard-Vannier E, Cohen-Jonathan S, Gautier J, Hervé-Aubert K, Munnier E, Soucé M, Legras P, Passirani C, Chourpa I.

Eur J Pharm Biopharm. 2012 Aug;81(3):498-505. doi: 10.1016/j.ejpb.2012.04.002. Epub 2012 Apr 10.

PMID:
22510695
16.

Disposition of nanoparticle-based delivery system via inner ear administration.

Chen G, Zhang X, Yang F, Mu L.

Curr Drug Metab. 2010 Dec;11(10):886-97. Review.

PMID:
21208174
17.

The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells.

Cruz LJ, Tacken PJ, Fokkink R, Figdor CG.

Biomaterials. 2011 Oct;32(28):6791-803. doi: 10.1016/j.biomaterials.2011.04.082. Epub 2011 Jul 2.

PMID:
21724247
18.

Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis.

Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, Knauer SK, Bantz C, Nawroth T, Bier C, Sirirattanapan J, Mann W, Treuel L, Zellner R, Maskos M, Schild H, Stauber RH.

ACS Nano. 2011 Sep 27;5(9):7155-67. doi: 10.1021/nn201950e. Epub 2011 Aug 25.

PMID:
21866933
19.

Influence of nanoparticle shape, size, and surface functionalization on cellular uptake.

Ma N, Ma C, Li C, Wang T, Tang Y, Wang H, Moul X, Chen Z, Hel N.

J Nanosci Nanotechnol. 2013 Oct;13(10):6485-98. Review.

PMID:
24245105
20.

Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review).

Huang RB, Mocherla S, Heslinga MJ, Charoenphol P, Eniola-Adefeso O.

Mol Membr Biol. 2010 Aug;27(4-6):190-205. doi: 10.3109/09687688.2010.499548. Review. Corrected and republished in: Mol Membr Biol. 2010 Oct;27(7):312-27.

PMID:
20615080
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk